Explore the vast range of titles available.

Airborne fungi are one of the most ubiquitous kinds of inhalant allergens which can result in allergic diseases. Fungi tend to grow in warm and humid environments with regional and seasonal variations. Their nomenclature and taxonomy are related to the sensitization of immunoglobulin E (IgE). Allergic cross-reactivity among different fungal species appears to be widely existing. Fungus-related foods, such as edible mushrooms, mycoprotein, and fermented foods by fungi, can often induce to fungus food allergy syndrome (FFAS) by allergic cross-reactivity with airborne fungi. FFAS may involve one or more target organs, including the oral mucosa, the skin, the gastrointestinal and respiratory tracts, and the cardiovascular system, with various allergic symptoms ranging from oral allergy syndrome (OAS) to severe anaphylaxis. This article reviews the current knowledge on the field of allergic cross-reactivity between fungal allergens and related foods, as well as the diagnosis and treatment on FFAS.

To improve the accuracy of photogrammetric joint roughness coefficient (JRC) estimation, this study proposes two optimization models based on ground sample distance (GSD), point density, and the root mean square error (RMSE) of checkpoints. First, an algorithm that automatically generates spatial positions for equipment based on the convergence strategy was developed, using principles of Structure from Motion and Multi-View Stereo (SfM-MVS) and the shooting parameter selection algorithm (SPSA). Second, a portable positioning plate containing ground control points and checkpoints was designed based on optical principles, and a moving camera capture strategy guided by SPSA was proposed. Combining SPSA, portable positioning plate, and moving camera capture strategy, a photogrammetric experiment for small-scale rock samples in the field was conducted, collecting 48 datasets with different shooting parameters. Subsequently, a dataset incorporating GSD, point density, RMSE, and three JRC estimation metrics was established, revealing their correlations and sensitivities. Using seven machine learning algorithms, optimization models for photogrammetric JRC accuracy were developed, with Linear Multidimensional Regression and Gaussian Process Regression models improving JRC accuracy by an average of 85.73%. Finally, the applicability and limitations of the newly proposed method were further discussed.

Purpose: To investigate the major allergen components associated with birch pollen allergy in northern China and elucidate clinical relevance to pollen food allergy syndrome (PFAS). Methods: Fifty-eight patients were recruited for a cross-sectional study and categorized into two groups: PFAS group and non-PFAS group, as well as apple allergy group and non-apple allergy group. The sIgE levels of birch pollen and its components, namely Bet v 1, Bet v 2, Bet v 4, and Bet v 6, were analyzed. Results: Among 58 participants, 44 individuals (75.9%) reported PFAS. 32 out of 44 (72.7%) participants reported apple allergy. Bet v 1 exhibited the highest sensitization rate at 82.8%, followed by Bet v 2 (29.3%) and Bet v 6 (1.7%). The combined sensitization rate for Bet v 1 and/or Bet v 2 was 93.1%. A total of 77.6% of the subjects demonstrated sensitization to single component, while 19.0% exhibited sensitization to two components. The sIgE levels of birch pollen and Bet v 1 were significantly elevated in PFAS group compared to non-PFAS group (p=0.001, p<0.001, respectively), as well as in apple-allergic and non-apple-allergic group (p<0.001, p<0.001, respectively). The optimal cut-off values for birch pollen and Bet v 1 sIgE were determined to be 7.09 kUA/L (with a sensitivity of 84.1% and specificity of 78.6%) and 5.11 kUA/L (with a sensitivity of 75.0% and specificity of 85.7%) when diagnosing PFAS. In terms of apple allergy, the optimal cut-off value were 9.40 kUA/L (with a sensitivity of 81.3% and specificity of 76.9%) and 6.53 kUA/L (with a sensitivity of 84.4% and specificity of 84.6%), respectively. Conclusion: The predominant sensitization pattern is mono-sensitization to Bet v 1, but when considering immunotherapy, Bet v 2 should also be taken into account. Bet v 1 serves as a valuable biomarker for diagnosing PFAS and apple allergy. Keywords: birch pollen, allergen component, Bet v 1, pollen food allergy syndrome, apple allergy

Omalizumab has been proven effective and safety in treating seasonal allergic rhinitis (SAR) by several randomized clinical trials in many countries. However, there is lack of clinical reports of Chinese patients with SAR treated by omalizumab. In the present real-world-designed study, we aimed to investigate the effectiveness of omalizumab in treating patients with SAR. SAR patients administered omalizumab in various dosages were recruited, and follow-up was done. Their quality of life (QOL) and symptoms were assessed by the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Total Nasal Symptoms Score (TNSS), Asthma Control Test (ACT), and clinical outcomes were compared between post- and pre-treatment conditions. Sixty SAR patients received omalizumab therapy in the study (mean age 35.47±17.02 years, 35 females). Omalizumab treatment significantly improved the quality of life (change in RQLQ overall score: -2.08±1.01, paired -test p<0.001) and nasal symptoms (change in TNSS: -7.33±2.50, paired -test p<0.001) of SAR patients. In 21 patients with co-existing asthma, the ACT score significantly increased from 16.10 to 22.57 on average (paired -test p<0.001), indicating better-controlled asthma. Using a threshold of ≥1 point improvement in RQLQ overall score, 83.3% of patients responded to omalizumab. The responder group had a higher baseline RQLQ score and TNSS (p<0.05), but both responders and non-responders had comparable scores after treatment. Multiple linear regression analysis identified the baseline RQLQ overall score as a predictor of change in the RQLQ score in omalizumab-treated SAR. Omalizumab is effective and safe in SAR treatment in a real-world setting.

Limited is known on the profiles of apple allergy in China. To explore the clinical significance of apple allergen components in northern China. This study recruited 40 participants and categorized into apple tolerance (  = 19) and allergy (  = 21) group. The latter was categorized into oral allergy symptoms (OAS,  = 14) and generalized symptoms (GS,  = 7). All participants underwent ImmunoCAP screening to assess sIgE levels of birch, apple, and their components. The sensitization rates were 90% for Bet v 1, 85% for Mal d 1, 35% for Bet v 2, and 20% for Mal d 3. The overall positive rate for apple allergens was 97.5%, with half demonstrating mono-sensitization to Mal d 1. Birch, Bet v 1 and Mal d 1 sIgE levels had consistent areas under the curve (AUC 0.747,  = 0.037; AUC 0.799,  = 0.012; AUC 0.902,  < 0.001 respectively) in diagnosing apple allergy. The optimal cut-off values were determined to be 22.85 kUA/L (63.6% sensitivity, 85.7% specificity), 6.84 kUA/L (81.8% sensitivity, 71.4% specificity) and 1.61 kUA/L (93.8% sensitivity, 75.0% specificity), respectively. No allergens or components demonstrated diagnostic value in distinguishing between OAS and GS. Mal d 3 sensitization was correlated with mugwort allergy and higher risk of peach, nuts or legumes generalized allergy. Mal d 1 was major allergen and the best for diagnosing apple allergy. Mal d 3 does not necessarily indicate severe allergic reaction to apples in northern China but may indicate mugwort sensitization and an increased risk of peach, nuts or legumes allergy.

Background There has been research about the prevalence and risk factors of eczema, hay fever, and asthma in children, but little is known about these conditions in adults in China. Objectives To explore the prevalence of adult eczema/atopic dermatitis (AD) and its risk factors in northern China. Methods A cluster sampling randomized population-based survey was conducted using a face-to-face questionnaire combined with skin prick tests of ten common aeroallergens including nine pollen allergens and Dermatophagoides pteronyssinu (Dp) allergen. The questionnaire was designed by specialists and included questions on the prevalence of eczema, hay fever, and asthma, socioeconomic risk factors, family history of atopy and environmental exposures. The prevalence of eczema with asthma and/or hay fever (EAH) was applied as a proxy of AD in this study. Results Overall, 2096 subjects were enrolled and completed the study. The prevalence of eczema was 15.7% (95% CI 14.3–17.4), while the prevalence of hay fever and asthma were 20.6% (95% CI 18.9–22.4) and 6.5% (95% CI 5.5–7.6), respectively. In particular, the prevalence of EAH was 5.1% (95% CI 4.4–7.0). The prevalence of eczema and EAH was significantly associated with younger age, atopy family history, high education level, urbanization, and antibiotic overuse ( P  < 0.05, logistic regression). The sensitization rate was higher in EAH compared with eczema (48.2% vs 41.0%, P  = 0.018), with weed pollen sensitization being the most common. Subjects with two or more concomitant allergic diseases had increased risk of eczema and EAH ( P  < 0.001). Allergen sensitization increased the risk of eczema and EAH ( P  < 0.001, both). Conclusions Adult eczema and EAH are prevalent in northern China under high pollen exposure. Socioeconomic and environmental factors affected the prevalence of adult AD in China. Dp had a particular impact on the prevalence of eczema/AD in the grassland region.

The coexistence of atopic dermatitis and eosinophilic gastroenteritis represents an uncommon clinical phenotype that is often underrecognized, resulting in delayed diagnosis and suboptimal treatment. This report aims to delineate the clinical characteristics of such cases and highlight recent developments in diagnostic and therapeutic approaches, thereby supporting improved clinical decision-making. A 50-year-old man presented with widespread atopic dermatitis-like cutaneous lesions and recurrent gastrointestinal symptoms consistent with eosinophilic gastroenteritis. Symptom exacerbation exhibited seasonal variation, particularly during spring and autumn. Laboratory investigations revealed elevated eosinophil percentages and absolute counts, as well as increased total serum IgE and positive specific IgE to allergens. Histopathological examination of gastroscopy and colonoscopy biopsy specimens demonstrated marked eosinophilic infiltration of the gastrointestinal mucosa, confirming the diagnosis of eosinophilic gastroenteritis accompanied by atopic dermatitis. Although oral antihistamines provided temporary symptomatic relief, clinical symptoms recurred after medication withdrawal. Atopic dermatitis and eosinophilic gastroenteritis appear to share a common allergen-driven pathogenesis. Accurate identification of causative allergens, in conjunction with the assessment of serum IgE levels and eosinophil counts, is critical for effective diagnosis and management. Therapeutic interventions targeting allergic inflammation have demonstrated efficacy in addressing both conditions.

Cationic polyacrylamide (CPAM) is a commonly used flocculant for water treatment. Factors that affect the flocculation effect and can be controlled manually include the type and dosage of CPAM, wastewater pH, stirring time and settling time, and their reasonable setting is critical to the flocculation effect of CPAM. In this paper, the optimal flocculation conditions of a novel CPAM were studied. First, single-factor tests were conducted to preliminarily explore the optimal range of factors that influence CPAM flocculation, and then response surface methodology (RSM) tests were performed to accurately determine the optimums of the influencing factors. The results showed that the flocculation effect was better when the intrinsic viscosity was larger or the cationic degree of CPAM was higher. The CPAM dosage, wastewater pH and stirring time significantly impacted the flocculation effect, and inflection points were observed. A model that could guide CPAM-8.14-40.2 flocculation was obtained by RSM tests. The model optimization showed that the optimal flocculation conditions of CPAM-8.14-40.2 for treating wastewater prepared with kaolin were as follows: the CPAM dosage, wastewater pH and stirring time were 5.83 mg·L−1, 7.28, and 5.95 min, respectively, and the turbidity of the treated wastewater was reduced to 6.24 NTU.

Background Artemisia weed pollen allergy is important in the northern hemisphere. While over 350 species of this genus have been recorded, there has been no full investigation into whether different species may affect the allergen diagnosis and treatment. This study aimed to evaluate the variations in amino acid sequences and the content of major allergens, and how these affect specific IgE binding capacity in representative Artemisia species. Methods Six representative Artemisia species from China and Artemisia vulgaris from Europe were used to determine allergen amino acid sequences by transcriptome, gene sequencing and mass spectrometry of the purified allergen component proteins. Sandwich ELISAs were developed and applied for Art v 1, Art v 2 and Art v 3 allergen quantification in different species. Aqueous pollen extracts and purified allergen components were used to assess IgE binding by ELISA and ImmunoCAP with mugwort allergic patient serum pools and individual sera from five areas in China. Results The Art v 1 and Art v 2 homologous allergen sequences in the seven Artemisia species were highly conserved. Art v 3 type allergens in A. annua and A. sieversiana were more divergent compared to A. argyi and A. vulgaris . The allergen content of Art v 1 group in the seven extracts ranged from 3.4% to 7.1%, that of Art v 2 from 1.0% to 3.6%, and Art v 3 from 0.3% to 10.5%. The highest IgE binding potency for most Chinese Artemisia allergy patients was with A. annua pollen extract, followed by A. vulgaris and A. argyi , with A. sieversiana significantly lower. Natural Art v 1-3 isoallergens from different species have almost equivalent IgE binding capacity in Artemisia allergic patients from China. Conclusion and clinical relevance There was high sequence similarity but different content of the three group allergens from different Artemisia species. Choice of Artemisia annua and A. argyi pollen source for diagnosis and immunotherapy is recommended in China.

Thirty thousand infants are born every year with congenital hearing impairment in mainland China. Racial and regional factors are important in clinical diagnosis of genetic deafness. However, molecular etiology of hearing impairment in the Tibetan Chinese population living in the Tibetan Plateau has not been investigated. To provide appropriate genetic testing and counseling to Tibetan families, we investigated molecular etiology of nonsyndromic deafness in this population. A total of 114 unrelated deaf Tibetan children from the Tibet Autonomous Region were enrolled. Five prominent deafness-related genes, GJB2, SLC26A4, GJB6, POU3F4, and mtDNA 12S rRNA, were analyzed. Inner ear development was evaluated by temporal CT. A total of 106 Tibetan hearing normal individuals were included as genetic controls. For radiological comparison, 120 patients, mainly of Han ethnicity, with sensorineural hearing loss were analyzed by temporal CT. None of the Tibetan patients carried diallelic GJB2 or SLC26A4 mutations. Two patients with a history of aminoglycoside usage carried homogeneous mtDNA 12S rRNA A1555G mutation. Two controls were homozygous for 12S rRNA A1555G. There were no mutations in GJB6 or POU3F4. A diagnosis of inner ear malformation was made in 20.18% of the Tibetan patients and 21.67% of the Han deaf group. Enlarged vestibular aqueduct, the most common inner ear deformity, was not found in theTibetan patients, but was seen in 18.33% of the Han patients. Common molecular etiologies, GJB2 and SLC26A4 mutations, were rare in the Tibetan Chinese deaf population. The mutation spectrum of hearing loss differs significantly between Chinese Tibetan patients and Han patients. The incidence of inner ear malformation in Tibetans is almost as high as that in Han deaf patients, but the types of malformation vary greatly. Hypoxia and special environment in plateau may be one cause of developmental inner ear deformity in this population.